|
Posted: 12:25 PM Sep 22, 2008
Genzyme opens new research center in Framingham
Genzyme Corp. has opened a new 180,000-square foot science center in Framingham where researchers will work on discovering new treatments for a range of ailments including Parkinson's disease, cancer and heart disease.
|
|
0 Comments
Font Size:
FRAMINGHAM, Mass. (AP) -- Genzyme Corp. has opened a new 180,000-square foot science center in Framingham where researchers will work on discovering new treatments for a range of ailments including Parkinson's disease, cancer and heart disease.
The Cambridge-based biotechnology company opened the facility Monday. It is expected to employ up to 350 people.
Researchers at the center will focus on medical areas including genetic, immune, kidney and cardiovascular diseases, endocrinology and neurological disorders.
The facility meets federal "green building" standards and uses an estimated 26 percent less energy and 40 percent less water than a comparable conventional building.
(Copyright 2008 by The Associated Press. All Rights Reserved.)
More Stories
- Pot-based prescription drug looks for FDA OK
4 Comments - Tenn. striving to curb pain pill epidemic
3 Comments - TennCare pain pill prescriptions up 48 percent
2 Comments - Axelrod defends administration birth control rule
2 Comments
Looking For A Business?
| Powered: Local.com |
| Popular Searches |
Stock Indexes
- .DJI
- 12853.64
- +52.41
- 0.41%
- .INX
- 1349.15
- +6.51
- 0.48%
- .IXIC
- 2922.85
- +18.97
- 0.65%
- NYA
- 8042.45
- +50.42
- 0.63%
Enter Ticker Symbal to get quote:
Quotes updated every 15 minutes
Quotes updated every 15 minutes
Stock Quotes
KnoxvilleLaw.TV
